To establish a baseline for comparison to the scaffolds, the effectiveness of the Cdk2 shRNA encoding plasmid (pKD-Cdk2-v5) was checked by transfecting MCF-7 breast cancer cells growing in culture. The gene discussed is CDK2; the disease is breast cancer.